Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04145934 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of a Multicomponent Walking Aid Program for People With MS
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT04145934 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 78 participants.
The verdict
NCT04145934, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
This is a randomized controlled trial of the Assistive Device Selection, Training, and Education Program (ADSTEP). ADSTEP is a training program of six weekly one-on-one sessions with a physical therapist intended to reduce falls among people who use a hand-held walking aid, such as a cane or a walker. ADSTEP focuses on training in the use of the walking aid, and includes gait evaluation, walking aid selection and fitting, and progressive task-oriented training with the walking aid. Participants will be randomized to receive ADSTEP or a waitlist control intervention; those in the control condition will receive National MS Society brochures on fall prevention and walking aid selection, and a letter will be sent informing their care provider that the subject reports falling. All subjects will complete an assessment visit at baseline, and follow-up assessments at about 8 weeks and about 6 months after that. Subjects will complete paper questionnaires of patient reported outcomes (PROs), a modified Functional Gait Assessment / Dynamic Gait Index, and will track fall sustained over their participation in the study using monthly paper fall calendars. At the end of study participation, all subjects in the control group will be offered the opportunity to receive ADSTEP.
Interventions
- BEHAVIORAL ADSTEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2020-02-06 |
| Est. Completion | 2023-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04145934
The ClinicalTrials.gov registry entry for NCT04145934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ADSTEP is the first listed.
NCT04145934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04145934 about?
NCT04145934 is a clinical study titled "A Randomized Controlled Trial of a Multicomponent Walking Aid Program for People With MS". This is a randomized controlled trial of the Assistive Device Selection, Training, and Education Program (ADSTEP). ADSTEP is a training program of six weekly one-on-one sessions with a physical therapist intended to reduce falls among people who use a hand-held walking aid, such as a cane or a walke...
What is the current status of trial NCT04145934?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2020-02-06. Estimated completion is 2023-01-26.
What interventions are being tested in trial NCT04145934?
The interventions under investigation include: ADSTEP (BEHAVIORAL).
Who is sponsoring clinical trial NCT04145934?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.